Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07219667 · ClinicalTrials.gov registry record · NA

South Asians With Type 2 Diabetes at Risk for Depression

A NA study, sponsored by NYU Langone Health.

Not yet
Registry status
NA
Development phase
100
Enrollment target

NCT07219667: Clinical Trial NA study, sponsored by NYU Langone Health.

NCT07219667 is a NA study that has not yet begun recruiting, run by NYU Langone Health. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07219667, a NA study, has not yet begun recruiting, sponsored by NYU Langone Health.

NOT YET RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target

Study Summary

This study will adapt a community health worker (CHW)-led Type 2 diabetes (T2D) intervention to include mental health and digital components using a trauma informed care approach, and test the feasibility and acceptability of this intervention to support South Asians with T2D at risk for depression.

Primary Outcome

Change in glycated hemoglobin (HbA1c).

Interventions

  • BEHAVIORAL CHW-led T2D Intervention

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2027-08-01
Est. Completion 2028-06-01
Phase NA
NYU Langone Health

1,164 total trials

What is known before NCT07219667 opens enrollment

NCT07219667 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 1 intervention - of which CHW-led T2D Intervention is the first listed.

NCT07219667 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07219667 about?

NCT07219667 is a clinical study titled "South Asians With Type 2 Diabetes at Risk for Depression". This study will adapt a community health worker (CHW)-led Type 2 diabetes (T2D) intervention to include mental health and digital components using a trauma informed care approach, and test the feasibility and acceptability of this intervention to support South Asians with T2D at risk for depression.

What is the current status of trial NCT07219667?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2027-08-01. Estimated completion is 2028-06-01.

What interventions are being tested in trial NCT07219667?

The interventions under investigation include: CHW-led T2D Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT07219667?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07219667's enrollment target sits among peer trials

100 840th of 2000 higher than 1,081 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07219667, the US trial registry maintained by the National Library of Medicine. NCT07219667 (mid enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.